← Leaderboards
Leroy F Liu
Univ Of Med/Dent Nj-R W Johnson Med Sch
$9,409,862
Attributed
$9,409,862
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $969.1K · FY2005–13$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$9,409,862 · 5
By mechanism
R01$8,124,451 · 4
T32$1,285,411 · 1
Top collaborators
No co-investigators on record.
Most similar at Univ Of Med/Dent Nj-R W Johnson Med Sch
Same institution · by research overlap
- Peter Lobel$16,507,235
- Zhaohui Feng$7,437,486
- Ling Qin$10,712,593
Others in their field
Top investigators on “Ubiquitin”
- Rama K Mallampalli · Ohio State University$30,048,445
- Ze'ev A Ronai · Mount Sinai School Of Medicine Of Cuny$28,079,720
- Alexander J Varshavsky · California Institute Of Technology$27,808,765
- Jeffrey Wade Harper · Dana-Farber Cancer Inst$25,447,325
- Daniel J Finley · Harvard University (Medical School)$23,295,342
- Mark Hochstrasser · University Of Chicago$18,674,039
Research focus
UbiquitinDna DamageCamptothecinDna TopoisomerasesNeoplastic CellMolecularComplexMediatingPharmaceutical PreparationsEnzyme MechanismPathway InteractionsProteinsBaseDrug Delivery SystemsAnimal ModelMouse ModelMulticatalytic Endopeptidase ComplexCancer TherapyClinicGenesLeadNeoplasm /Cancer PharmacologyGene ExpressionDown-Regulation
Grant awards (39)
MECHANISM OF ACTION OF ANTITUMOR DRUGS$254,856
R01 · FY2013 · CA · contact PI
MECHANISM OF ACTION OF ANTITUMOR DRUGS$266,008
R01 · FY2012 · CA · contact PI
Mechanism of Action of TOP2-Directed Anticancer Drugs$232,123
R01 · FY2012 · CA · contact PI
Mechanism of Action of TOP2-Directed Anticancer Drugs$65,820
R01 · FY2012 · CA · contact PI
Mechanism of Action of TOP2-Directed Anticancer Drugs$295,020
R01 · FY2011 · CA · contact PI
MECHANISM OF ACTION OF ANTITUMOR DRUGS$266,008
R01 · FY2011 · CA · contact PI
Mechanism of Action of TOP2-Directed Anticancer Drugs$295,316
R01 · FY2010 · CA · contact PI
MECHANISM OF ACTION OF ANTITUMOR DRUGS$274,236
R01 · FY2010 · CA · contact PI
Mechanism of Action of TOP2-Directed Anticancer Drugs$289,525
R01 · FY2009 · CA · contact PI
MECHANISM OF ACTION OF ANTITUMOR DRUGS$274,236
R01 · FY2009 · CA · contact PI
Training in Cancer Pharmacology$129,372
T32 · FY2009 · CA · contact PI
Mechanism of Action of TOP2-Directed Anticancer Drugs$281,093
R01 · FY2008 · CA · contact PI
Training in Cancer Pharmacology$276,333
T32 · FY2008 · CA · contact PI
Mechanisms of Action in Antitumor Drugs$265,396
R01 · FY2008 · CA · contact PI
Training in Cancer Pharmacology$329,928
T32 · FY2007 · CA · contact PI
Mechanism of action of TOP2-directed anticancer drugs$272,031
R01 · FY2007 · CA · contact PI
Mechanisms of Action in Antitumor Drugs$265,396
R01 · FY2007 · CA · contact PI
Training in Cancer Pharmacology$368,138
T32 · FY2006 · CA · contact PI
Mechanism of action of TOP2-directed anticancer drugs$280,156
R01 · FY2006 · CA · contact PI
Mechanisms of Action in Antitumor Drugs$273,322
R01 · FY2006 · CA · contact PI
Mechanisms of Action in Antitumor Drugs$47,463
R01 · FY2006 · CA · contact PI
Mechanism of action of TOP2-directed anticancer drugs$286,898
R01 · FY2005 · CA
Mechanisms of Action in Antitumor Drugs$279,900
R01 · FY2005 · CA
Training in Cancer Pharmacology$181,640
T32 · FY2005 · CA
Mechanisms of Action in Antitumor Drugs$46,263
R01 · FY2005 · CA
Mechanism of action of TOP2-directed anticancer drugs$286,898
R01 · FY2004 · CA
Mechanisms of Action in Antitumor Drugs$279,900
R01 · FY2004 · CA
Topoisomerase I-directed Anticancer Drugs$279,460
R01 · FY2004 · CA
Mechanisms of Action in Antitumor Drugs$22,418
R01 · FY2004 · CA
Topoisomerase I-directed Anticancer Drugs$279,460
R01 · FY2003 · CA
MECHANISMS OF ACTION IN ANTITUMOR DRUGS$254,089
R01 · FY2003 · CA
Topoisomerase I-directed Anticancer Drugs$279,460
R01 · FY2002 · CA
MECHANISMS OF ACTION IN ANTITUMOR DRUGS$246,689
R01 · FY2002 · CA
FUNCTIONAL AND MECHANISTIC STUDIES OF DNA TOPOISOMERASES$308,840
R01 · FY2001 · GM
MECHANISMS OF ACTION IN ANTITUMOR DRUGS$239,505
R01 · FY2001 · CA
FUNCTIONAL AND MECHANISTIC STUDIES OF DNA TOPOISOMERASES$350,378
R01 · FY2000 · GM
MECHANISMS OF ACTION IN ANTITUMOR DRUGS$232,528
R01 · FY2000 · CA
PROTOBERBERINES AS DUAL POISONS OF TOPOISOMERASES$225,952
R01 · FY2000 · CA
FUNCTIONAL AND MECHANISTIC STUDIES OF DNA TOPOISOMERASES$27,808
R01 · FY2000 · GM